Qualitest acquires Israel’s Comply, a pharma and digital health assurance specialist
The acquisition for an undisclosed sum comes only two months after Qualitest's acquisition of QA Infotech
Qualitest, an AI-powered, engineering-driven software and quality assurance company, has announced that it has acquired Comply, an Israeli quality assurance specialist specifically in Pharma and Digital Health. The deal will result in Qualitest absorbing 83 of Comply’s employees and will add Teva, Merck, Johnson & Johnson, GE Medical, and AbbVie to Qualitest’s list of clients. The acquisition's price tag was not disclosed.“Qualitest is a global leader in testing, which is why it’s the perfect partner to help us take our testing services worldwide,” said Gai Anbar, Founder and CEO at Comply. “We have been impressed with Qualitest’s position as the go-to provider for software testing. By joining forces, we can capitalize on our own expertise in providing the highest quality assurance for health and pharma businesses,” he added. QA Infotech. Qualitest itself was acquired by Bridgepoint in 2019.
“We’ve had our eyes on Comply for a while due to its reputation as a leader in providing software testing services to the growing pharma tech market,” said Norm Merritt, Qualitest CEO. “That’s why we are excited to bring them into the Qualitest family. We see a lot of potential in the pharma industry, and by integrating Comply’s expertise we can expand Qualitest’s footprint in this hot-growth area,” he added.Qualitest was founded in 1997 and helps brands graduate beyond functional testing to more modern-day innovations such as automation, AI, and crowd-sourced UX testing. Its technology is used across a myriad of industries, such as entertainment, consumer goods, retail, gaming, and more.